Teucrium Sugar Fund Financials
This page shows Teucrium Sugar Fund (CANE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Liquidity, not leverage, defines this structure: a cash-heavy balance sheet is carrying losses better than the income line suggests.
The key read-through is the disconnect between reported loss and cash erosion: net loss was-$26.5M , yet year-end cash was still$205.3M . Because cash had been$210.9M a year earlier and liabilities were only$17.0M in the last fully reported balance sheet, earnings volatility is not mapping one-for-one into funding stress.
The losses have also been shrinking over the last three annual periods, moving from
The reported weakness does not look expense-driven: SG&A was just
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Teucrium Sugar Fund's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Key Financial Metrics
Earnings & Revenue
Teucrium Sugar Fund reported -$26.5M in net income in fiscal year 2025. This represents an increase of 44.6% from the prior year.
Cash & Balance Sheet
Teucrium Sugar Fund held $205.3M in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Capital Allocation
CANE Income Statement
| Metric | Q1'26 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.6M | N/A | N/A | $2.0M | N/A | N/A | $11.1M | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $74K | N/A | N/A | $71K-9.2% | $78K+10.5% | $71K+28.0% | $55K+4.5% | $53K |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $2.6M | N/A | N/A | $3.0M-13.6% | $3.5M-4.9% | $3.7M-19.0% | $4.6M-1.4% | $4.6M |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $30.4M+1077.9% | -$3.1M | N/A | -$56K+99.5% | -$10.9M+53.5% | -$23.5M-366.1% | $8.8M+130.4% | -$29.0M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CANE Balance Sheet
| Metric | Q1'26 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $737.8M | N/A | $241.7M-6.1% | $257.4M-4.0% | $268.0M-9.6% | $296.7M-9.0% | $326.0M-11.7% | $369.0M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $641.4M+235.6% | $191.2M-9.4% | $210.9M-9.6% | $233.3M+2.3% | $228.1M-10.1% | $253.7M-13.2% | $292.2M-9.4% | $322.5M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $3.9M | N/A | $17.0M+67.0% | $10.2M-62.2% | $27.0M+43.0% | $18.9M+65.3% | $11.4M-58.4% | $27.4M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $733.9M | N/A | $224.6M-9.1% | $247.2M+2.5% | $241.0M-13.2% | $277.8M-11.7% | $314.5M-7.9% | $341.6M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CANE Cash Flow Statement
| Metric | Q1'26 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.7M | N/A | N/A | -$1.6M-911.4% | $199K+100.8% | -$25.5M-555.4% | $5.6M+114.6% | -$38.3M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $427.5M | N/A | N/A | $6.9M+126.6% | -$25.8M-97.5% | -$13.1M+63.6% | -$35.9M-172.1% | $49.8M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $5.0M | N/A | N/A | $25.3M-47.1% | $47.8M+77.9% | $26.9M-52.4% | $56.4M+46.9% | $38.4M |
CANE Financial Ratios
| Metric | Q1'26 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 93.2% | N/A | N/A | -2.8% | N/A | N/A | 79.3% | N/A |
| Return on Equity | 4.1% | N/A | N/A | -0.0%+4.5pp | -4.5%+3.9pp | -8.5%-11.3pp | 2.8%+11.3pp | -8.5% |
| Return on Assets | 4.1% | N/A | N/A | -0.0%+4.1pp | -4.1%+3.8pp | -7.9%-10.6pp | 2.7%+10.6pp | -7.9% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.01 | N/A | 0.08+0.0 | 0.04-0.1 | 0.11+0.0 | 0.07+0.0 | 0.04-0.0 | 0.08 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
Is Teucrium Sugar Fund profitable?
No, Teucrium Sugar Fund (CANE) reported a net income of -$26.5M in fiscal year 2025.
How financially healthy is Teucrium Sugar Fund?
Teucrium Sugar Fund (CANE) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.